Evidence map›Paper›PMID 37756258›Full record

ArticlePloS one2023

Successful delivery of viviparous lantern shark from an artificial uterus and the self-production of lantern shark luciferin.

Taketeru Tomita, Minoru Toda, Atsushi Kaneko, Kiyomi Murakumo, Kei Miyamoto, Keiichi Sato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Taketeru TomitaOkinawa Churashima Research Institute, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.ORCID 0000-0002-9924-6566
Minoru TodaOkinawa Churaumi Aquarium, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.
Atsushi KanekoOkinawa Churaumi Aquarium, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.
Kiyomi MurakumoOkinawa Churashima Foundation Veterinary Hospital, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.
Kei MiyamotoOkinawa Churashima Research Institute, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.
Keiichi SatoOkinawa Churashima Research Institute, Okinawa Churashima Foundation, Motobu, Okinawa, Japan.
Okinawa Churashima Foundation · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our recent success in the long-term maintenance of lantern shark embryos in artificial uterine systems has provided a novel option for the medical treatment of premature embryos for captive viviparous elasmobranchs. The remaining issue with this system is that the embryos cannot survive the abrupt change in the chemical environment from artificial uterine fluid (AUF) to seawater during delivery. To overcome this issue, the present study developed a new protocol for seawater adaptation, which is characterized by a long-term and stepwise shift from AUF to seawater prior to delivery. This protocol was employed successfully, and the specimen survived for more than seven months after delivery, the longest captive record of the species. During the experiment, we unexpectedly detected bioluminescence of the embryonic lantern shark in the artificial uterus. This observation indicates that lantern sharks can produce luciferin, a substance for bioluminescence. This contradicts the recent hypothesis that lantern sharks lack the ability to produce luciferin and use luciferin obtained from food sources.

Indexed as

SharksUterine DiseasesAnimalsFemaleHumansLuciferinsSeafoodUterusLuciferins

Identifiers

PMID37756258
PMCPMC10530027
OpenAlexW4387113867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.